Cysteine is an essential requirement in living organisms. However, due to its
reactive thiol side chain, elevated levels of intracellular cysteine can be
toxic and therefore need to be rapidly eliminated from the cellular milieu. In
mammals and many other organisms, excess cysteine is believed to be primarily
eliminated by the cysteine dioxygenase dependent oxidative degradation of
cysteine, followed by the removal of the oxidative products. However, other
mechanisms of tackling excess cysteine are also likely to exist, but have not
thus far been explored. In this study, we use Saccharomyces
cerevisiae, which naturally lacks a cysteine dioxygenase, to
investigate mechanisms for tackling cysteine overload. Overexpressing the high
affinity cysteine transporter, YCT1, enabled yeast cells to
rapidly accumulate high levels of intracellular cysteine. Using targeted
metabolite analysis, we observe that cysteine is initially rapidly
interconverted to non-reactive cystine in vivo. A time course
revealed that cells systematically convert excess cysteine to inert thiol forms;
initially to cystine, and subsequently to cystathionine,
S-Adenosyl-L-homocysteine (SAH) and S-Adenosyl L-methionine (SAM), in addition
to eventually accumulating glutathione (GSH) and polyamines. Microarray based
gene expression studies revealed the upregulation of arginine/ornithine
biosynthesis a few hours after the cysteine overload, and suggest that the
non-toxic, non-reactive thiol based metabolic products are eventually utilized
for amino acid and polyamine biogenesis, thereby enabling cell growth. Thus,
cells can handle potentially toxic amounts of cysteine by a combination of thiol
trapping, metabolic redistribution to non-reactive thiols and subsequent
consumption for anabolism.